Non-motor Symptoms in Parkinson Disease: A Target for Neuropalliative Care Intervention
Objective: To identify various non-motor symptoms experienced by individuals with PD and to assess the likelihood of these symptoms being treated relative to individuals without…Correlational Analysis between Anxiety and Self-perception of Health in Patients with and without Idiopathic Parkinson’s Disease without Dementia.
Objective: To analyze the impact of anxiety on self-perception of health in patients with Idiopathic Parkinson's Disease Without Dementia. Background: After depression in Idiopathic Parkinson's…Sexual Health Decline in Women with Parkinson’s Disease: A Two-Year Follow-Up Study
Objective: To investigate the long-term decline in sexual health among women with Parkinson’s disease (PD) over a two-year period. Background: Sexual dysfunction (SD) is a…The Benefits of Whole-Body Electro Muscle Stimulation (WB-EMS) in a patient with Parkinson’s Disease
Objective: To determine the motor and non-motor benefits of WB-EMS in a patient with Parkinson’s disease Background: Parkinson’s disease causes both motor and non-motor symptoms.…The Complexity of Neuropsychiatric Symptoms Assessment in Parkinson’s Disease: A Rasch Analysis of the Mild Behavioral Impairment-Checklist
Objective: This study aims to evaluate the psychometric properties of the Mild Behavioral Impairment-Checklist (MBI-C) in Parkinson’s Disease (PD) using Rasch measurement theory. Background: The…Structural changes in the retina and their correlation with the severity of non-motor symptoms in patients with Parkinson’s disease.
Objective: To evaluate the association between retinal structural changes, as measured by optical coherence tomography (OCT), and non-motor symptoms severity in patients with Parkinson’s disease…Relationship Between Improvement in “On” Time, Nonmotor Symptoms, and Quality of Life in Adults Treated With Foslevodopa/Foscarbidopa in Advanced Parkinson’s Disease
Objective: To determine if adults with advanced Parkinson’s disease (aPD) treated with a 24‑hour/day continuous subcutaneous foslevodopa/foscarbidopa (LDp/CDp) infusion who had ≥ 1‑hour improvement in…Clinical Manifestations and Rate of Progression of Parkinsons Disease in Different Regions
Objective: To determine the differences in the age of onset of clinical manifestations and rate of progression of Parkinson's disease in different regions of Tajikistan.…Vagus nerve ultrasound and its association with non-motor symptoms in parkinson’s disease
Objective: To evaluate the vagus nerve (VN) diameter with ultrasonography in Parkinson’s disease (PD) patients compared to healthy controls and explore its relationship with non-motor…Positive Relationship Between Improvement in Sleep and Quality of Life During Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion
Objective: To investigate the relationship between improvements in sleep disturbances and quality of life (QoL) in adults with advanced Parkinson’s disease (aPD) treated with a…
- 1
- 2
- 3
- …
- 55
- Next Page »